Pursuant to the provisions of Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Gujarat Kidney & Superspeciality has informed that it enclosed the transcript of the Earnings call with Analysts / Investors held on Thursday, November 05, 2026, post declaration of the Financial Results for the quarter and half year ended September 30, 2026. The same has also been disseminated on the website of the Company.
The above information is a part of company’s filings submitted to BSE.